Genevation LTD
PrivateMomentum
Top 1%
of companies Caplight tracks
Company Overview
Genevation LTD is a biotechnology company that develops personalized mRNA cancer vaccines using an AI-driven, cell-free neoantigen identification platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genevation LTD Comparables
Compare Genevation LTD with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| myNEO Therapeutics | 83% | |
| Gritstone bio | 77% | |
| RNAimmune | 76% | |
Genevation LTD Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased to 3, 150% of headcount.
- Mar 1, 2026
Monthly visitors increased 887% MoM.
Genevation LTD Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genevation LTD's valuation, stock price, and market status.